Periodic Reporting for period 2 - NeuroLF (NeuroLF: The best small and mobile dedicated brain PET scanner for an accessible early detection of Alzheimer’s disease )
Berichtszeitraum: 2021-04-01 bis 2022-09-30
We have performed the clinical study ExploreBPET to evaluate the existing prototype in the clinic and identifies aspects to be improved for the current development of NeuroLF.
Meanwhile, we have completed the development of NeuroLF and started to submit the technical documentation to TÜV Süd. With feedback and test results we are fixing the remaining bugs and aim to obtain the CE mark in 2023.
We have started to be visible in the public and have showcased the company and our product NeuroLF on several fairs and congresses. First pre-sales contracts are in sight and will be signed shortly.